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Abstract 
Objective: A qualitative study of PwMS who had clinically significant levels of 
anxiety was conducted to gain a richer perspective on their experience. The objective 
was to explore PwMS’ experiences of anxiety and their perspectives on causes and 
outcomes.  
Design: Twenty in depth, semi-structured interviews were conducted with PwMS 
consecutively recruited from the Neurology Department of a NHS University 
Hospital. Sixteen had a relapsing-remitting course, three had a secondary progressive 
course and one person had primary progressive MS. Interviews were recorded, 
transcribed and analysed using inductive thematic analysis.  
Results: Although participants thought different factors had initially triggered their 
anxiety, being given the diagnosis of MS appeared to be the most significant factor 
for many participants. Difficulties in the workplace and in relationships, particularly 
related to perceived dependence on others were also important themes. A wide range 
of emotional responses and negative thinking were associated with anxiety; this 
suggested the presence of comorbid depression. Participants were able to 
acknowledge the positive and negative coping strategies that impacted on their 
anxiety.  
Conclusion: This review confirms that anxiety can have many negative implications 
for PwMS and suggests that early detection and intervention are necessary in order to 
improve patient wellbeing.  
 
Key words: anxiety, multiple sclerosis, chronic illness, mental health, qualitative 
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Introduction 
Anxiety can be defined as an excessive feeling of unease and worry which individuals 
find difficult to control, that consequently interferes with their everyday life 
(American Psychiatric Association, 2000). Worldwide estimates of the proportion of 
the population who are likely to experience anxiety in their lifetime range between 
0.8% and 9% (Kessler, Petukova, Sampson, Zaslavsky, & Wittchen, 2012; Kessler & 
Wang, 2008). However, for PwMS, anxiety has been found to affect between 15.8% 
and 57% of the population (Feinstein, O'Connor, Gray, & Feinstein, 1999; Garfield & 
Lincoln, 2012). 
 
Multiple Sclerosis (MS) is a chronic inflammatory neurological condition of the 
central nervous system (DeLuca, Genova, Hillary, & Wylie, 2008). Mental health 
difficulties such as depression and anxiety have been found to be particularly 
common among PwMS (Janssens et al., 2003). Anxiety symptoms have been found to 
be amongst the most disabling, impacting overall health and quality of life (Fruhwald, 
Loffler-Stastka, Eher, Saletu, & Baumhackl, 2001). For PwMS, anxiety may be 
severe and prolonged due to the individual’s concern about the uncertain outcome of 
future episodes and the potential seriousness of the symptoms (Cecile et al., 2004).   
 
Anxiety among PwMS has been associated with fatigue, younger age of onset (Wood 
et al., 2013), chronic pain (Kalia & O'Connor, 2005), being female, previous episodes 
of depression, suicidal thoughts, alcohol abuse, social stressors (Wood et al., 2013) 
and level of disability (Tsivgoulis et al., 2007).  A recent systematic review (Butler, 
Matcham, & Chalder, 2016) highlighted that anxiety among PwMS is associated with 
a number of physical, cognitive, social and psychological factors rather than just the 
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illness itself.  The review also drew attention to the high levels of anxiety that exist 
among PwMS and the need for early intervention and treatment of anxiety throughout 
the course of MS. 
A limited number of qualitative studies have examined the experience of MS. A study 
exploring the experience of women with MS reported that the physical and emotional 
aspects of MS were intertwined and the emotional impact of living with a 
deteriorating and unpredictable condition was emphasized (Blundell Jones, Walsh, & 
Isaac, 2014). This draws attention to the need for further analysis on emotional 
experiences related to unpredictability. Other research drew attention to the impact of 
MS on the self; this impact did not inevitably mean a loss of self but instead a 
changing self; one capable of dynamism as well as stability (Mozo-Dutton, Simpson, 
& Boot, 2012). Research examining adjustment in early stage MS reported MS as a 
distressing and intrusive condition but found that information, support, problem-
focused coping, goal adjustment, a positive outlook and a fighting spirit were 
effective in maintaining an acceptable level of well- being for participants (Dennison, 
Yardley, Devereux, & Moss-Morris, 2010). These coping strategies however were not 
examined in relation to anxiety or at later stages of adjustment. Furthermore, recent 
qualitative research on adjustment reported that some factors identified as influencing 
adjustment are more difficult to modify (e.g. illness progression and social 
environment) than others (e.g. emotional reactions, concealing/revealing the condition 
and perceptions of environment). However, overall the factors that are modifiable are 
likely to be even more important as the illness progresses and could be incorporated 
into future interventions (Bogosian, Morgan, Bishop, Day, & Moss-Morris, 2017). 
These will be important to consider in the context of anxiety for PwMS.  
Anxiety has been relatively neglected within the MS literature in comparison to topics 
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such as depression and cognition despite its clear importance for PwMS (Lobentanz et 
al., 2004). Specifically there is a deficit of qualitative studies on this topic. Therefore, 
it would be beneficial for research to examine how anxiety fits into the MS picture 
independently from depression through qualitative interviews. This study aims to gain 
a comprehensive understanding of anxiety from the perspective of PwMS, by 
exploring their views of the factors that influence, determine and impact their anxiety. 
Implications of such research include suggestions for interventions that could benefit 
PwMS.   
Methods  
People with MS were screened for anxiety using the hospital anxiety and depression 
scale (HADS) by a mental health nurse at a National Health Service (NHS) University 
hospital in the United Kingdom. Participants were included if they were diagnosed 
with MS, over 18 years old and were experiencing anxiety. Twenty patients who 
scored 11 or above on the anxiety sub-scale of the HADS were consecutively 
recruited from one hundred and twenty consecutively assessed patients.  Participants 
had been diagnosed with MS between two and twenty-seven years previously. 
Materials 
The HADS was chosen as it was previously found to be a reliable measure of 
depression and anxiety in a hospital setting (Zigmond & Snaith, 1983) and has been 
specifically validated for use with PwMS (Honarmand & Feinstein, 2009). The cut-
off point of 11 was chosen as this has been reported to be the optimal cut-off point for 
patients who experience a high probability of experiencing clinically significant 
anxiety (Zigmond & Snaith, 1983). Within the study, the average anxiety score for 
participants was 14.15 (S.D. = 2.96). For depression, the average score was 10.2 
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(S.D.= 4.04). Overall, the average combined distress score for all participants was 
23.5 (S.D.= 6.61).  
Design 
Semi-structured interviews were conducted to explore the nature of anxiety and 
related concerns that PwMS and anxiety held. The interview schedule devised was 
based on discussions with clinicians and patients seen in the clinic and focused on the 
potential sources of anxiety for PwMS. It consisted of eighteen semi-structured 
questions (see Table 1). The interviews were held over the phone by two postgraduate 
psychologists who were completing a master’s degree in mental health. This was for 
the convenience of the participants as they were able to do this in their own home 
without having to travel. The interviews were recorded.  
(Insert Table 1: Interview Schedule Questions) 
Before the interview, participants were given the opportunity to ask any questions and 
were told they could withdraw from the study at any time. Semi-structured interviews 
were conducted using the interview schedule. The interviews lasted between thirty 
and sixty minutes (mean time=42.16 minutes). All participants were offered a follow-
up session after the interview with the MS mental health nurse if they wanted it. This 
was to ensure that the participants were supported with any undue distress caused by 
the topics raised. 
Each interview was audio-recorded and subsequently transcribed verbatim following 
the data protection guidelines by the first author (EB). The transcript was then 
examined against the audio recording to ensure accuracy. Responses were then 
analysed using the inductive thematic analysis procedure (Braun & Clarke, 2006). For 
this analysis, the interviews were initially read repeatedly to identify meaningful units 
 7 
of text relevant to the topic. Secondly, units of text were coded and assigned a 
descriptive name in Nvivo 10 software by the first author. When possible, these codes 
reflected participants’ vocabulary and were redefined and combined, with new and 
alternative codes being generated (Glaser & Straus, 2012). Broader themes were 
identified and organised into a preliminary framework. Written accounts of themes 
were repeatedly checked against transcripts to ensure they accurately represented the 
data (Patton, 1990).  The same unit of text could be included in more than one 
category (Tesch, 1990). The data was systematically reviewed to ensure that a name, 
definition and an exhaustive set of data to support each category was identified. 
Finally, the categories were grouped into themes and sub themes. Interviewing 
continued until data saturation was reached and no new themes were being identified.  
To increase the robustness of the analysis, every second interview was independently 
coded by the second author (RT). Thematic coding, identification of  themes and 
construction of the final framework occurred through discussions amongst three of the 
authors (EB, RT and TC). Areas of disagreements were resolved by consensus. This 
analysis was conducted in line with published guidelines on qualitative analysis 
(Elliott, Fischer, & Rennie, 1999). 
Findings 
Table 2 describes the sample. The majority were women, single, white British, 
educated to at least A level (final examinations for secondary or pre-university 
education) and their MS was more likely to have a relapsing remitting course. 
 
(Insert Table 2.) 
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Inductive thematic analysis led to four main themes from the interviews. The number 
of participants whose responses featured under each theme is indicated (See Table 3) 
and a diagram of the themes is illustrated (see Figure 1).  
 
(Insert Table 3: Summary of main themes and subthemes) 
(Insert Figure 1: Thematic representation of themes related to anxiety in people 
with MS) 
 
How it began (the development of anxiety) 
Big life events 
Fifteen of the participants mentioned the development of anxiety early in life. This 
was often linked to key events that triggered symptoms. For example, one participant 
felt that her adoption was likely to have contributed to her current mental state.  
‘I was adopted quite young so the loss of mother..’ (P11) 
 
Other stressful life events that formed the basis for other participants’ anxious 
tendencies were associated with seeing a close family member go through a 
debilitating sickness. For example, P7’s father was diagnosed with motor-neurone 
disease and P5’s sister contracted meningitis.  
‘I was sixteen when my oldest sister got meningitis and had to have her limbs 
amputated and that was a pretty horrific ordeal for my whole family. It made me very 
anxious’ (P5) 
 
It’s part of my personality 
Seven of the participants linked anxiety symptoms to their personality. For example, 
P9 described herself as always feeling like an anxious person.  
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‘I kind of think of myself as a slightly uptight and anxious person’ (P9) 
Four participants suggested that an anxious temperament followed by the diagnosis of 
MS, magnified their anxiety levels.  
‘Obviously it happened before (the diagnosis) but just not as severe’ (P1) 
For the remaining participants, their experiences with anxiety began with the 
diagnosis of MS.  
Response to my diagnosis 
A diagnosis of MS had a profound effect on the mental state of the participants. P3 
recalled the diagnosis as an ‘upsetting’ time that caused ‘a total panic’. P8 too, 
associated her anxiety to her first appointment with the neurologist, who at first 
wrongly associated her symptoms with a stroke. Some participants felt a sense of 
disbelief.  
‘I found it quite hard at first to accept the diagnosis and I thought for a long time it 
could be something else’ (P16) 
“ I was quite worried because you know something is wrong but you don't know what 
it is, you don't know how serious it is and what's going to happen to you”. (P2) 
Two of the participants had close family members who had been diagnosed with MS. 
They felt this intimate knowledge of MS symptoms was likely to have triggered their 
anxiety when they were diagnosed themselves. The unavailability of treatment and 
information and lack of predictability of the illness at diagnosis further triggered 
anxiety for many of the participants.  
‘Being told that you have a condition where there is no cure, there is no available 
treatment, I mean you are on death-row’ (P17) 
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Getting on with life (impact on life with MS and Anxiety) 
MS and anxiety making each other worse 
One of the main triggers for anxiety that became apparent during the interviews was 
the severe physical symptoms that patients had to learn to cope with as the illness 
progressed.  
Pain appeared to be a key factor.  
‘Sometimes I cannot get out of bed without a struggle because of the pain of 
everything due to the MS’ (P14) 
P18 had difficulty with hand movements and this impacted on her daily life as a 
mother of small children.   
‘I can’t unscrew medicine bottles so the children have to unscrew their own medicine 
bottles’ 
Cognitive difficulties associated with MS such as a difficulty processing thoughts 
were also found to be an anxiety-provoking factor.  
‘The thoughts don’t sort of come out sort of as quick [...] so that brings up a lot of 
anxiety for me’ (P10) 
A relapse or a decline in physical functioning further triggered anxiety as the illness 
progressed.   
‘If my MS is playing up I get anxious’ (P9) 
Overall, the uncertainty surrounding the progression and the course of the illness was 
a major concern.  
‘What’s going to happen? Am I going to have another relapse, Will I get worse?’ (P6) 
It became apparent throughout the interviews that anxiety could act as a trigger for a 
relapse or ‘flare-up’. P2 recalled her most recent relapse that occurred 6 years ago; 
she spoke of the time as being a stressful period in her life, as she had a cancer scare.  
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‘The massive relapse that I had 6 years ago [...] came about because I thought I had 
breast cancer [...] and I was stressing so I know for me that it’s stress that makes my 
MS worse’ (P2) 
Work-life struggles 
The impact of MS symptoms on work ability was a major contributor to high levels of 
anxiety. For P3, her anxieties were based around finance, as she had not worked full 
time in the past few months due to her fatigue. P3 felt that no one would hire her.  
‘When there’s someone perfectly fit and able [...] in the same position’ (P3) 
P1 experienced anxiety, hiding her MS condition from her company, as she felt 
disclosing her illness may impact her career prospects adversely. She felt she would 
be viewed as a ‘liability’. Instead she said she would rather ‘lie and deal with the 
consequences’. P7 felt a constant anxiety in her work-life regarding how much she 
could do while simultaneously being under pressure to earn money.  
‘I actually wonder what I can handle so that's a bit of a kind of worry because 
obviously I have to earn money so I have an underlying anxiety around all the work 
stuff if I am honest’ (P7) 
 P4’s anxieties concerning work developed due to the lack of support she received and 
she believed this led to a worsening of her MS symptoms. She spoke of being 
‘targeted’ and a ‘burden’ as a result of having MS.  
P5 worried that her colleagues would see her MS as a ‘weakness’, therefore she ‘over-
compensates’ because she does not ‘want people to know the problems’ she 
experiences. This feeling of vulnerability due to MS symptoms was prominent 
throughout the interviews; participants felt that their MS symptoms put them at a 
disadvantage in the workplace.  
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Family and friends 
Participants worried about the impact their MS would have on those around them, 
particularly their partners.  
‘It has put quite a strain on the marriage actually…. it is sometimes quite difficult for 
my husband to accept it’ (P16) 
P8 was concerned about whether her husband would stay with her due to the 
difficulties of caring for someone with MS. For other participants, anxiety was linked 
to whether others would accept their illness. Participants also worried about the 
loyalty of their friends, as some MS symptoms inhibited their social lives and their 
participation in activities they once enjoyed. P17 mentioned her dependence on others 
and how this caused anxiety for her.  
“I feel like I have to keep on asking people to do basic things. I cannot even walk out 
the front door without somebody helping me” (P17). 
“I just don’t feel me”  
Embarrassment  
Eighteen of the participants said that they experienced several other strong emotions 
as well as anxiety. One of the common themes from participant responses was 
embarrassment at having MS associated with perceived stigma surrounding the 
disease.   
‘The sense of embarrassment that you get that seems too irrational but you do feel 
really embarrassed about the whole thing and like what people would think of you’ 
(P5) 
Six participants spoke of a time when they were experiencing a ‘flare up’ and they felt 
others around them thought they were drunk. This appeared to cause distress, as they 
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believed many members of the public have a lack of knowledge about MS and its 
associated symptoms.  
Worry 
All of the participants conveyed worry about what would happen to them in the future 
and how they would cope with the uncertainty of the illness. Participants did not feel 
they were in control of what was happening with their bodies, which often led to a 
sense of frustration.  
‘It's the not knowing that's hard to deal with’ (P16) 
Fear 
Fearful thoughts about the future triggered anxiety, particularly when severe 
symptoms were present. Participants were worried about the consequences the 
illness would have on their lives.  
‘One of my worst fears is being in a wheelchair’ (P20) 
Loneliness 
Many participants had smaller social circles and restricted social lives, which had 
occurred since their diagnosis was made. The change was attributed to the severity of 
MS symptoms.  
‘I feel terrible about being in a wheelchair... You just feel so isolated really’ (P15) 
Sadness 
Negative thoughts appeared to be strongly linked to anxiety symptoms for many 
participants.  
‘I tend to go straight to the negative all the time. My default setting is anything I do 
will turn out disastrous and usually it doesn't’ (P11) 
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Hopeless thoughts were also consistently mentioned throughout the interviews 
highlighting the high level of comorbidity.  
‘I question the existence of life and all the rest of it. You think of ending your life…. 
it’s hard to carry on sometimes’ (P17) 
Coping  
What works 
Since the diagnosis of their MS, many participants developed helpful coping 
strategies to deal with the impact of their illness. One participant believed that a 
healthy diet was more beneficial than drugs.  
‘Diets do more than the drugs to some degree’ (P9) 
Many participants said that since their diagnosis of MS, exercise had helped reduce 
their anxiety levels and had been beneficial for their overall wellbeing. One 
participant stated that this is something she would like to do daily to reduce anxiety.  
‘The immediate thing is I need to be keeping active. At least it’s something that I am 
going to be doing everyday’ (P12) 
Rest, relaxation and living positively in the moment also appeared to have beneficial 
effects.  
‘I try to stay clear from stress and stressful situations which does help to reduce 
anxiety levels’ (P14) 
What can make things worse 
Unhelpful coping strategies for dealing with MS and anxiety were most often linked 
to denial and avoidance.  
‘It’s like I block it out like a coping mechanism. Maybe I find it too painful to go 
there’ (P11) 
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P4 acknowledged that she might still be in ‘denial’ about having MS as she did not 
have any visible symptoms.  
The consumption of alcohol and cannabis was also frequently mentioned as a coping 
strategy. However, it has been debated as to whether the positive consequences of 
smoking cannabis or drinking alcohol outweigh the negative or vice versa. For 
example, four participants mentioned that cannabis relieved painful MS symptoms 
and anxiety. However, participants also stated that it was an illegal drug with other 
potentially harmful effects.  
‘I have been smoking weed all my life and now more because of the MS. … it makes 
the stabbing and sharp pain in the morning…a dumber pain. It’s not as fierce’ (P20) 
Other participants spoke of a ‘glass or two of wine’ after a long stressful day to 
relieve anxiety.  
 
Discussion  
This study provides a unique insight into the experiences of anxiety in the context of 
MS. The PwMS’ interviews provided vivid and detailed descriptions of their anxiety. 
Often anxiety was linked to the unpredictability of the illness and the significant 
impact it had on their daily lives. However, it was also associated with life 
experiences and personality factors, which are important to account for to gain a full 
understanding of anxiety in the context of MS. It was clear that a variety of emotional 
reactions such as worry and embarrassment were all linked and a distinct emotional 
reaction was uncommon; this is similar to previous research which reported that 
women struggled emotionally with many aspects of living with MS (Blundell Jones et 
al., 2014). The stigma associated with MS symptoms was commonly linked to these 
emotional reactions. Previous research suggested that social stigma may be 
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experienced through being ignored or conversely overemphasizing the symptoms of 
MS (Grytten & Maseide, 2006).  
Many of the participants reported significant emotional distress and negative thoughts 
related to their anxiety. This is in line with previous literature that reported anxiety 
can co-occur with depressive symptoms in 75% of MS patients (Bamer, Amtmann, 
Ehde, & Johnson, 2008). In a prospective study, depression was the only factor that 
significantly predicted whether someone was anxious or not, accounting for 46% of 
variation (Garfield & Lincoln, 2012). A recent systematic review of the literature also 
highlighted high levels of comorbid anxiety and depression among PwMS (Butler et 
al., 2016). Greater focus on the co-existence of depression and anxiety amongst 
PwMS is needed to establish the most appropriate intervention (Bamer et al., 2008). 
The severity of anxiety symptoms among PwMS is supported by prior empirical 
research. A lifetime prevalence of clinically significant anxiety is 18.6% for PwMS in 
contrast with 5.1% for the general population (Aarsland & Figved, 2007). In this 
study, level of disability was consistently mentioned as a factor provoking anxiety for 
participants and is in line with previous research (Aloulou et al., 2011; Askari et al., 
2014; Beiske et al., 2008; Butler et al., 2016). However, a lack of correlation between 
anxiety and disability has been found by some who suggest anxiety is a psychological 
reaction to the impact of the disease (Sidorenko, Boyko, & Gusev, 2010).  
Although some participants reported previous experiences of anxiety, being given a 
MS diagnosis played a crucial role in the development of anxiety symptoms for some. 
This echoes previous research that reported anxiety is often prominent at the time of 
MS diagnosis disclosure, especially for women (Giordano et al., 2011). Interestingly, 
MS related symptoms often induced anxiety but also anxiety could trigger MS related 
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symptoms. This relationship has been reported in previous research highlighting the 
bidirectional effects between depression/anxiety and severity of medical illness 
(Katon, 2003). Helping the patient to clearly identify the nature of the symptoms may 
help them to develop more effective coping skills. Further research is warranted to 
further explore this complex bidirectional relationship.   
Many participants reported their MS diagnosis increased their anxiety in the 
workplace. At work some participants reported that they concealed their illness, some 
reduced their workload and some overcompensated to avoid being perceived as weak. 
Research has reported that workplace stress-related interventions are likely to be very 
valuable for those with a chronic illness such as MS (McGonagle & Barnes-Farrell, 
2014). Specifically, interventions using social modeling to enhance self-efficacy may 
be helpful to prevent identity threat experiences (Bandura, 1994). The MS literature 
has highlighted that self-efficacy based interventions can also reduce feelings of 
loneliness and improve overall social functioning (Amtmann et al., 2012; Kalina & 
Hinojosab, 2016). 
Participants were also extremely anxious about how their illness affected their close 
relationships with partners and friends. A common worry was that partners would 
leave due to increasing dependence within the relationship as previously reported 
(Mozo-Dutton et al., 2012).  Research has highlighted that individuals in all cultures 
are likely to strive for norms and values within their own culture (Heine, Lehman, 
Markus, & Kitayama, 1999). Within western culture, value is typically placed on 
being an independent, self-contained, autonomous entity (Markus & Kitayama, 1991). 
This is a possible explanation for why this change in independence can bring up 
anxiety for PwMS living in western cultures. Future research should explore the loss 
 18 
of independence in other cultural contexts to investigate the role cultural norms may 
play in living with MS.  However, it is important to note that many PwMS indicated 
that if they had good social support they felt less of a burden on others and felt they 
were better at coping. This is in line with previous research on coping which found 
that the more MS patients perceived their family circle as being available, the more 
they used problem-focused coping (Rommer, Sühnel, König, & Zettl, 2017; Roy-
Bellina, Moitrelle, Camu, & Gely-Nargeot, 2009).  
 
Accounts from this study highlight the significant need for psychological 
interventions for PwMS. The comorbidity of anxiety and depression highlights the 
need for interventions that target both anxiety and depression together as higher levels 
of depression are linked to poorer response of anxiety symptoms to CBT (Martinsen, 
Olsen, Tonset, Nyland, & Aarre, 1998). Trans-diagnostic or ‘unified’ treatments have 
been proposed for PwMS (McEvoy, Nathan, & Norton, 2009) as they use the same 
underlying treatment principles across mental health difficulties, without changing the 
protocol to suit specific diagnoses (Chorpita, Taylor, Francis, Moffitt, & Austin, 
2004). In trans-diagnostic treatments the common maintaining processes of 
psychological difficulties are targeted within the one protocol. One of the most widely 
supported approaches of these types of interventions is broad-spectrum trans-
diagnostic CBT (TD-CBT) (Barlow, 2000). This applies core CBT-based treatment 
principles and techniques such as graded exposure and cognitive restructuring to 
target the common processes underlying anxiety and depression. A systematic review 
of existing literature on these types of treatments for depression and anxiety in adults 
found large and significant reductions in both anxiety and depression, and moderate 
improvements in quality of life (Newby, McKinnon, Kuyken, Gilbody, & Dalgleish, 
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2015).  
A Working Conceptual Model of Anxiety for PwMS based on Beck’s model of 
emotional disorders has been proposed (Butler et al., 2016). The model assumes that 
anxiety can be triggered by critical events, which may include developing the disease, 
fear of disability or other life stressors. Subsequently, avoidance coping, anxiety, low 
mood or stress and unhelpful thinking maintain the symptoms. Despite PwMS stating 
clearly that they thought psychological interventions were important, research has 
reported that 52% of patients with clinically significant anxiety were not receiving 
any type of psychotherapy nor medication for anxiety (Aarsland & Figved, 2007). 
Greater access to psychological services for PwMS is therefore necessary. 
However,the psychological intervention, whether it be focused specifically on 
anxiety or transdiagnostic issues, should address the individual concerns of the 
patient. This can be done by carrying out a detailed assessment focusing on their 
specific preoccupations. An individualized formulation can then be shared with 
the patient and collaboratively a way forward can be agreed. From a 
pharmacological perspective, serotonin reuptake inhibitors have been recognised as 
first-line treatment in depression comorbid with a spectrum of anxiety difficulties. 
Short-acting benzodiazepines (BZDs) have also been considered as an important 
‘bridging strategy’ to target an acute anxiety component (Coplan, Aaronson, 
Panthangi, & Kim, 2015).  
Shortcomings of this qualitative study need to be acknowledged. The method of data 
collection by telephone may have impacted participant responses. This method may 
restrict the ability to develop rapport. However, research has indicated that telephone 
interviews can be effective in qualitative research (Sturges & Hanrahan, 2004) and 
participants can be more willing to share sensitive information (Novick, 2008). The 
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detailed descriptions and the length of the interviews indicate that our telephone inter- 
views provided rich and trustworthy data. Furthermore, it is important to consider that 
interviewer characteristics can impact participant responses. However, response bias 
appeared to be minimal as interviewees spoke honestly, demonstrated by their 
willingness to share stories they may have found embarrassing and were open about 
their emotional responses.  
A higher proportion of women were interviewed compared to men. However, a study 
based on the largest, most ethnically representative survey of the U.S. population to 
date found that women were more likely than men to meet criteria for all anxiety 
disorders examined, with the exception of Social Anxiety Disorder (SAD) (McLean, 
Asnaani, Litz, & Hoffmann, 2011). It has also been suggested that a gender ratio 
approaching 4:1 of female to male diagnosis exists in MS (Orton et al., 2006). It is 
important therefore to consider this when interpreting results. Although the sample 
was recruited consecutively, thereby not introducing a selection bias, the sample was 
selected from a group of patients who were anxious. Further qualitative studies should 
focus on those who are coping as well as those who are not. In addition the majority 
of the participants were those with relapsing remitting MS. It would be interesting to 
explore in more depth the views of those with primary progressive MS. Although 
only three of our sample had progressive MS this reflects the prevalence rates in the 
population (Minderhoud, van der Hoeven, & Prange, 1988) 
Data from qualitative research can be understood and interpreted in numerous ways. 
Taking this into consideration, the findings should be regarded as evocative thought-
provoking themes rather than definitive facts. Recall bias may also influence 
responses provided. Research has highlighted a tendency for people to recreate 
 21 
autobiographical memories in order to form a coherent, favourable view of their self 
in the moment (Wilson & Ross, 2003). It is also important to consider that question 2, 
4 and 9 of the interview schedule may have been responsible for particular responses 
however we felt they were important questions to consider in the context of the 
research question.   
In conclusion, the insights gained from this research may be of particular interest to 
clinicians involved in designing, developing or delivering interventions for anxiety 
among PwMS. This is the first qualitative study, to the author’s knowledge, explicitly 
examining anxiety in the context of MS and draws attention to the need for clinicians 
to consider the significant impact anxiety has on PwMS. The richness of the data 
draws attention to the specific impact anxiety has on PwMS and how this should be 
considered for each individual, especially in it’s development and role in everyday 
life. The findings also highlight the possible role of wider sociopolitical norms in 
living with MS, such as the value placed on independence in western society. One can 
imagine that living with the worry of a relapse is bound to be anxiety provoking. As 
to whether a relapse intensifies the anxiety is debatable and needs to be explored 
further.  In an extensive study examining mental health issues it was concluded that 
clinicians should evaluate all MS subjects for anxiety difficulties as they represent a 
treatable cause of disability in MS (Korostil & Feinstein, 2007). This study supports 
those findings and the value of providing psychological interventions within a model 
of stepped care including prevention, brief interventions and psychological and/or 
pharmacological treatment for those in most need. The specific contents of the 
interventions should address the specific concerns of the patients. This can be 
done by carrying out a detailed assessment focusing on the specific concerns of 
the patients. An individualized formulation can then be shared with the patient 
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and collaboratively a way forward can be agreed. Future research should focus on 
what approaches work best for PwMS and at what stage.   
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Tables 
 Table 1: Interview Schedule Questions 
Interview Schedule Questions 
1.Before you were diagnosed with MS did you experience excessive anxiety or 
worry?  
2. If yes what form did it take? Was it a generalized anxiety or anxiety due to being in 
a social situation or did you experience panic attacks or anxiety due to a specific 
phobia or anxiety due to a traumatic event?  
3. Can you tell me about when you began to experience excessive anxiety or worry?  
4. Do you think that there was a certain trigger that caused you to become worried or 
anxious? 
5.For how long would you say you would experience these anxieties for? Or is it on 
going?  
6.What do you feel anxious about? Currently do you have specific anxieties? 
7.Can you describe what takes place physically when you become anxious? 
8.Can you now describe the thought process that occurs when you are feeling 
anxious? 
9.Do you experience anxieties about having MS and the uncertainty of the illness? 
10.Do you have an MS attack directly after experiencing anxiety or vice versa? 
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11.Do you have a disability as a result of having MS and if so do you have any 
embarrassment about having a disability, or any of the aids that play a part in your life 
now? 
13.Do you experience anxiety about your social and work life and how MS will have 
an impact on this? 
14.Do you experience anxiety about having to be dependent on others? 
15. Do you experience anxiety about the future? 
16. How are you able to cope with such anxiety? - Do you have any specific coping 
strategies to deal with the anxiety? 
17. Do you find it helpful seeing the mental health nurse and discussing your 
anxieties? 
 
Table 2. Describes the sample  
Gender 18 females, 2 males 
Age 26-67 years (M= 41.75, S.D. = 10.98) 
Ethnicity 60% ‘White British’, 10% ‘White Other’, 
10% ‘Black British’, 10% ‘Black 
Caribbean’, 5% ‘West African’ & 5% 
‘Indian’ 
Education 60% University level, 35% A-Levels, 5% 
GCSE level, 
Marital status 40% married/living with a partner, 60% 
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single 
Type of MS 80% had a relapsing-remitting course, 
15% had a secondary progressive course, 
5% had primary progressive MS.  
 
Table 3: Summary of main themes and subthemes 
Theme and Sub-themes Number of 
participants  
1.      How it began (the development of 
anxiety) 
 
Big life events  8 
It’s part of my personality  7 
Response to my diagnosis 14 
2.       Getting on with life (with MS and 
Anxiety) 
 
MS and anxiety making each other worse 20 
Work-life struggles 20 
Family and Friends 19 
3.       “I just don’t feel me” (in response to 
MS and anxiety) 
 
Embarrassment 18 
Worry 20 
Fear  2 
Loneliness  6 
Sadness  12 
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4.       Coping   
What works 19 
What makes things worse  15 
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Figure 1: Thematic representation of themes related to anxiety in people with MS 
How it began  
Getting on 
with life  
“I just don’t 
feel me”  
• Big life events 
• It’s part of my 
personality 
• Response to my 
diagnosis  
 
 
• MS and anxiety 
making each 
other worse 
• Workplace 
struggles 
• Family and 
Friends 
 
 
• Embarrassment 
• Worry 
• Fear 
• Loneliness 
• Sadness 
Coping 
• What works 
o “The immediate thing is I need to 
be keeping active. At least it’s 
something that I am going to be 
doing everyday” 
• What makes things worse 
o “It’s like I block it out like a 
coping mechanism. Maybe I find 
it too painful to go there” 
